Abstract Details

Title Novel Genetic Animal Models of Autism: Molecular Mechanisms to Therapeutic Targets

Topic Child Neurology/Developmental Neurobiology

Presentation(s) (-)

Poster/Presentation
Number 002

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Craig M. Powell, MD, PhD, FAAN (UAB School of Medicine)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Mark R. Etherton, MD (Massachusetts General Hospital)	Dr. Etherton has received personal compensation for serving as an employee of Takeda Pharmaceutical Company. Dr. Etherton has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Argenica Therapeutics.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Thomas C. Sudhof	No disclosure on file

��ɫ����